MMX makes the most of mesalazine in ulcerative colitis

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1565, 2006-01, pp. : 13-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Delayed-Release Multi Matrix System (MMX™) Mesalazine: In Ulcerative Colitis

By McCormack Paul L.   Robinson Dean M.   Perry Caroline M.  

Drugs, Vol. 67, Iss. 17, 2007-01 ,pp. : 2635-2642

Adis International

Access to resources Recommend Favorite

MMX® Mesalazine: A Review of its Use in the Management of Mild to Moderate Ulcerative Colitis

By Yang Lily P.H.   McCormack Paul L.  

Drugs, Vol. 71, Iss. 2, 2011-01 ,pp. : 221-235

Adis International

Access to resources Recommend Favorite

Delayed-release MMX™ mesalazine: a guide to its use in ulcerative colitis

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 24, Iss. 5, 2008-05 ,pp. : 6-8

Adis International

Access to resources Recommend Favorite

Delayed-Release Multi Matrix System (MMX™) Mesalazine in Ulcerative Colitis: A Viewpoint by Åke Nilsson

By Nilsson Åke  

Drugs, Vol. 67, Iss. 17, 2007-01 ,pp. : 2643-2644

Adis International

Access to resources Recommend Favorite

Mesalazine micropellets effective in ulcerative colitis

By  

Inpharma, Vol. 1, Iss. 1475, 2005-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite